A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen

Drug-resistant tuberculosis (DR-TB) poses a new threat to global health; to improve the treatment outcome, therapeutic vaccines are considered the best chemotherapy adjuvants. Unfortunately, there is no therapeutic vaccine approved against DR-TB. Our study assessed the therapeutic efficacy of a reco...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicine & pharmacotherapy 2021-10, Vol.142, p.112047-112047, Article 112047
Hauptverfasser: Chiwala, Gift, Liu, Zhiyong, Mugweru, Julius N., Wang, Bangxing, Khan, Shahzad Akbar, Bate, Petuel Ndip Ndip, Yusuf, Buhari, Hameed, H.M. Adnan, Fang, Cuiting, Tan, Yaoju, Guan, Ping, Hu, Jinxing, Tan, Shouyong, Liu, Jianxiong, Zhong, Nanshan, Zhang, Tianyu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!